KRT26: A Potential Drug Target for Kidney Diseases (G353288)

Target Name: KRT26

NCBI ID: G353288

KRT26

KRT26: A Potential Drug Target for Kidney Diseases

KRT26 (Kidney Disease Receptor 26) is a protein that is expressed in the kidney, and it is involved in the regulation of renal function. Studies have shown that KRT26 plays a crucial role in the development and progression of kidney diseases, including diabetes, hypertension, and chronic kidney disease. As a result, KRT26 has become a focus of interest for researchers and pharmaceutical companies as a potential drug target or biomarker.

KRT26 is a transmembrane protein that is expressed in the brush border of the kidney epithelial cells. It is composed of four structural domains: a N-terminus, a T-terminus, a middle伪-helices region, and a C-terminus. The N-terminus of KRT26 is farnesylated, which is a hallmark of a protein that is involved in signaling pathways. The T-terminus of KRT26 contains a tyrosine residue, which is known to play a role in the regulation of protein stability and function. The middle伪-helices region of KRT26 contains several unique features, including a unique acidic amino acid at position 26 (E26) that is involved in the regulation of protein stability. The C-terminus of KRT26 contains a leucine residue, which is known to play a role in the regulation of protein stability and function.

KRT26 is involved in several signaling pathways that are important for renal function. One of the most well-studied signaling pathways that is involved in KRT26 is the TGF-β pathway. TGF-β is a cytokine that plays a role in the regulation of cellular growth, differentiation, and inflammation. KRT26 is known to be involved in the regulation of TGF-β signaling in the kidney.

In addition to its involvement in the TGF-β pathway, KRT26 is also involved in several other signaling pathways that are important for renal function. One of the other signaling pathways that is involved in KRT26 is the Wnt signaling pathway. Wnt is a cytokine that plays a role in the regulation of cellular growth, differentiation, and inflammation. KRT26 is known to be involved in the regulation of Wnt signaling in the kidney.

KRT26 is also involved in the regulation of several cellular processes that are important for renal function. One of the cellular processes that is involved in KRT26 is the regulation of sodium and water excretion. KRT26 is known to be involved in the regulation of the amount of sodium and water that is excreted by the kidney. KRT26 is also involved in the regulation of water excretion in the urine.

In addition to its involvement in several signaling pathways, KRT26 is also known to be involved in the regulation of several biological processes that are important for renal function. One of the biological processes that is involved in KRT26 is the regulation of inflammation in the kidney. KRT26 is known to be involved in the regulation of inflammation in the kidney, which is important for the development and progression of kidney diseases.

As a result of its involvement in several signaling pathways and its role in the regulation of several biological processes, KRT26 has become a focus of interest for researchers and pharmaceutical companies as a potential drug target or biomarker. Studies have shown that modulating KRT26 function can have a significant impact on the development and progression of kidney diseases. For example, studies have shown that inhibiting KRT26 function has the potential to slow down the progression of kidney diseases, such as diabetic nephropathy and chronic kidney disease. In addition, studies have shown that modulating KRT26 function can also have the potential to improve kidney function in individuals with chronic kidney disease.

In conclusion, KRT26 is a protein that is expressed in the kidney and is involved in

Protein Name: Keratin 26

The "KRT26 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT26 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets